Carl Zeiss Meditec AG (ETR:AFX – Get Free Report)’s share price rose 2.2% on Tuesday . The stock traded as high as €100.50 ($108.06) and last traded at €100.00 ($107.53). Approximately 91,338 shares traded hands during trading, a decline of 3% from the average daily volume of 94,405 shares. The stock had previously closed at €97.80 ($105.16).
Carl Zeiss Meditec Price Performance
The stock has a market cap of $8.94 billion, a PE ratio of 32.26, a P/E/G ratio of 3.70 and a beta of 0.90. The business has a fifty day simple moving average of €110.09 and a two-hundred day simple moving average of €100.04. The company has a current ratio of 3.40, a quick ratio of 2.47 and a debt-to-equity ratio of 7.16.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Featured Stories
- Five stocks we like better than Carl Zeiss Meditec
- How to Use Stock Screeners to Find Stocks
- Garmin Navigates to New Highs Driven By Wearables Trend
- The How And Why of Investing in Oil Stocks
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
